These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7488314)

  • 1. Binding affinities of isocarbacyclin methyl ester and its free acid to prostanoid receptors.
    Tanaka M; Kojima C; Muramatsu M; Tanabe H
    Arzneimittelforschung; 1995 Sep; 45(9):967-70. PubMed ID: 7488314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEI-9063, a stable and highly specific prostacyclin analogue for the prostacyclin receptor in mastocytoma P-815 cells.
    Negishi M; Hashimoto H; Yatsunami K; Kurozumi S; Ichikawa A
    Prostaglandins; 1991 Sep; 42(3):225-37. PubMed ID: 1723528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
    Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
    Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets.
    Crider JY; Xu SX; Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):253-8. PubMed ID: 11993717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
    Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
    J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
    Jones RL; Chan K
    Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
    Lerner RW; Lopaschuk GD; Catena RC; Olley PM
    Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
    Walsh MT; Kinsella BT
    Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
    Shin Y; Romstedt KJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
    Rowlands DK; Kao C; Wise H
    Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
    Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
    Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
    Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
    Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
    Shahbazian A; Heinemann A; Peskar BA; Holzer P
    Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.
    Sharif NA; Williams GW; Davis TL
    Br J Pharmacol; 2000 Nov; 131(6):1025-38. PubMed ID: 11082108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.